...
首页> 外文期刊>Journal of clinical and experimental hematopathology : >Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan
【24h】

Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan

机译:日本多中心和单中心Castleman病和TAFRO综合征的流行病学分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Castleman disease is a polyclonal lymphoproliferative disease which is clinically classified into unicentric (UCD) and multicentric (MCD). TAFRO syndrome is a relatively new concept that partly overlaps with MCD. Due to their rarity, their incidence remains unknown. This study investigated the incidence and prevalence of UCD, MCD, and TAFRO syndrome in Japan using a fixed-point observation method based on their incidence in Ishikawa prefecture. The annual incidences of MCD, UCD, and TAFRO syndrome in Japan were 309-731, 71-542, and 110-502, respectively, yielding annual incidence rates per million individuals of 2.4-5.8, 0.6-4.3, and 0.9-4.9, respectively, and nationwide prevalence of 4,180-14,900, 1,350-10,300, and 860-7,240, respectively. In conclusion, MCD, UCD and TAFRO syndrome may not be as rare as previously estimated in Japan.
机译:Castleman病是一种多克隆淋巴增生性疾病,临床上分为单中心(UCD)和多中心(MCD)。 TAFRO综合征是一个相对较新的概念,与MCD部分重叠。由于它们的稀有性,它们的发病率仍然未知。本研究基于石川县的UCD,MCD和TAFRO综合征在日本的发病率,采用定点观察方法对其进行了调查。在日本,MCD,UCD和TAFRO综合征的年发病率分别为309-731、71-542和110-502,每百万人的年发病率分别为2.4-5.8、0.6-4.3和0.9-4.9,全国范围的患病率分别为4,180-14,900、1,350-10,300和860-7,240。总之,MCD,UCD和TAFRO综合征可能并不像日本先前估计的那样罕见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号